A sleep-focused venture capital firm, Supermoon Capital has backed six companies thus far, including Tel Aviv-based Clair Labs, which creates a device that can monitor a patient’s sleep remotely, and EnsoData, a Madison, Wisconsin-based company that uses AI to help people with sleep apnea. 

Supermoon Capital raises $36 million for its debut fund from a limited partner base including family offices, high net worth individuals and some strategic backers like the inspiration for the fund, ResMed. The firm will focus on early-stage opportunities — pre-seed through Series A — and plans to invest in 13 to 15 companies from this capital batch. The firm may also look to incubate companies in-house if the right ideas or resources arise. “There is a huge need for a fund focused entirely on sleep,” Masterson says. “It’s truly the most important aspect of everyone’s daily lives. However, sleep science is really early and highly complex. We are able to serve as the bridge in-between.”

Supermoon is sector agnostic, Judge says, due to the fact that sleep — and the night market — touch so many aspects of life, from physical products like beds and sheets to medical diagnostics and treatments for conditions like sleep apnea. The firm is also interested in AI and enterprise-driven tech solutions to solve sleep problems, too.

The firm plans to pull from a network it’s built that includes sleep scientists and experts to evaluate potential investments and help portfolio companies to test products and get feedback. “We are pretty excited about the arsenal that we’ve assembled and how it creates a lot of differential value-add,” Masterson says. “It makes us quite attractive as a co-investor, as more generalist funds might be starting to look at sleep as a major investment opportunity.” Chris Fernandez agrees. The cofounder and CEO of EnsoData says he was thrilled to be able to work with a firm that had expertise in sleep and has been able to tap this network for help with studies and customer introductions. “It means a lot to have a venture fund completely focused on sleep,” Fernandez tells Forbes. “It brings a lot of validation. We collectively are at the beginning of our journey of really uncovering the real influence of sleep on human health and disease.”

Get the full story at forbes.com.